Company Rexahn Pharmaceuticals, Inc. Nyse
Equities
US7616402001
Biotechnology & Medical Research
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,608,506 | 23,942,205 ( 93.49 %) | 0 | 93.49 % |
Company contact information
Rexahn Pharmaceuticals, Inc.
15245 Shady Grove Road Suite 455
20850, Rockville
+(248) 957-9024
http://www.rexahn.comSector
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |